Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) Revenue (2016 - 2025)

Historic Revenue for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $1.3 million.

  • Arcadia Biosciences' Revenue fell 1528.95% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 1228.57%. This contributed to the annual value of $5.0 million for FY2024, which is 1326.9% up from last year.
  • According to the latest figures from Q3 2025, Arcadia Biosciences' Revenue is $1.3 million, which was down 1528.95% from $1.5 million recorded in Q2 2025.
  • Arcadia Biosciences' Revenue's 5-year high stood at $4.3 million during Q4 2021, with a 5-year trough of -$5.8 million in Q4 2022.
  • Over the past 5 years, Arcadia Biosciences' median Revenue value was $1.3 million (recorded in 2025), while the average stood at $1.3 million.
  • As far as peak fluctuations go, Arcadia Biosciences' Revenue soared by 65668.79% in 2021, and later tumbled by 23516.28% in 2022.
  • Arcadia Biosciences' Revenue (Quarter) stood at $4.3 million in 2021, then crashed by 235.16% to -$5.8 million in 2022, then soared by 113.37% to $777000.0 in 2023, then skyrocketed by 56.5% to $1.2 million in 2024, then grew by 7.07% to $1.3 million in 2025.
  • Its last three reported values are $1.3 million in Q3 2025, $1.5 million for Q2 2025, and $1.2 million during Q1 2025.